Literature DB >> 9641527

Effects of oxidative stress on prion protein expression in PC12 cells.

D R Brown1, B Schmidt, H A Kretzschmar.   

Abstract

PC12 cells are known to express the prion protein, a normal cell surface glycoprotein. This protein is upregulated in PC12 cells differentiated with nerve growth factor. A neurotoxic prion protein peptide, PrP106-126, is not toxic to PC12 cells alone. PrP106-126 is toxic to PC12 cells co-cultured with microglia and more so to NGF-differentiated PC12 cells. PC12 cells selected for resistance to either copper toxicity or oxidative stress have higher levels of PrP(C) expression. Both PC12 variants are more sensitive to the toxicity of PrP106-126. This suggests that PC12 sensitivity to PrP106-126 toxicity is related to prion protein expression and not to a state of high differentiation induced by NGF. Variants of PC12 cells that are more resistant to copper toxicity have higher levels of anti-oxidant enzymes, superoxide dismutase and glutathione peroxidase. Our results suggest that cells expressing higher levels of PrP(C) have higher resistance to oxidative stress or copper toxicity but are more sensitive to PrP106-126 toxicity. Prion protein expression may be involved in both the metabolism of copper and resistance to oxidative stress. Increased cellular resistance to copper toxicity may be partly related to increased activity of anti-oxidant enzymes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9641527     DOI: 10.1016/s0736-5748(97)00042-7

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  16 in total

Review 1.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

2.  Activation and repression of prion protein expression by key regions of intron 1.

Authors:  Josephine A Wright; Patrick C McHugh; Mark Stockbridge; Samantha Lane; Silvia Kralovicova; David R Brown
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

3.  Neurotropin® alleviates hippocampal neuron damage through a HIF-1α/MAPK pathway.

Authors:  Wen-Li Fang; De-Qiang Zhao; Fei Wang; Mei Li; Sheng-Nuo Fan; Wang Liao; Yu-Qiu Zheng; Shao-Wei Liao; Song-Hua Xiao; Ping Luan; Jun Liu
Journal:  CNS Neurosci Ther       Date:  2017-03-07       Impact factor: 5.243

Review 4.  Copper-dependent functions for the prion protein.

Authors:  David R Brown; Judyth Sassoon
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

5.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.

Authors:  A R White; S J Collins; F Maher; M F Jobling; L R Stewart; J M Thyer; K Beyreuther; C L Masters; R Cappai
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  PrPSc-like prion protein peptide inhibits the function of cellular prion protein.

Authors:  D R Brown
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

7.  Prion protein expression and superoxide dismutase activity.

Authors:  D R Brown; A Besinger
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 8.  Molecular advances in understanding inherited prion diseases.

Authors:  David R Brown
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

9.  Prion protein accumulation and neuroprotection in hypoxic brain damage.

Authors:  Neil F McLennan; Paul M Brennan; Alisdair McNeill; Ioan Davies; Andrew Fotheringham; Kathleen A Rennison; Diane Ritchie; Francis Brannan; Mark W Head; James W Ironside; Alun Williams; Jeanne E Bell
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

10.  Expression of cellular prion protein (PrP(c)) in schizophrenia, bipolar disorder, and depression.

Authors:  Serge Weis; Johannes Haybaeck; Jeannette R Dulay; Ida C Llenos
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.